CIK 0001703647 · Non-accelerated filer<br>Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472324450
- Phone
- 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-21 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −237 | $0.53 | $126 | 48,457 |
| 2023-08-21 | Lucchino David L. President and CEO | Sale 10b5-1 | −3,057 | $0.50 | $2K | 633,744 |
| 2023-08-18 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −227 | $0.63 | $143 | 48,694 |
| 2023-08-18 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,865 | $0.60 | $2K | 636,801 |
| 2023-08-17 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −230 | $0.62 | $143 | 48,921 |
| 2023-08-17 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,733 | $0.63 | $2K | 639,666 |
| 2023-08-16 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −234 | $0.67 | $157 | 49,151 |
| 2023-08-16 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,895 | $0.65 | $2K | 642,399 |
Page 10 of 10 · 188 trades